Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 51, 2010, Pages 22249-22254

  Li, Christopher ^a   Lasse, Samuel ^a   Lee, Pedro ^a   Nakasaki, Manando ^a   Chen, Shih Wei ^a   Yamasaki, Kenshi ^b   Gallo, Richard L ^b   Jamora, Colin ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; GELATINASE A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; MITOGEN ACTIVATED PROTEIN KINASE 14; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL ADHESION; CONTROLLED STUDY; DISEASE COURSE; ENZYME REGULATION; ENZYME REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN DISEASE; SPONGIOSIS;

ANIMALS; CADHERINS; CASPASE 8; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EPIDERMIS; HUMANS; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; WOUND HEALING;

EID: 78650667554     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1009751108     Document Type: Article

References (30)

1. Mueller MM (2006) Inflammation in epithelial skin tumours: Old stories and new ideas. Eur J Cancer 42:735-744.
2. Schäfer M, Werner S (2008) Cancer as an overhealing wound: An old hypothesis revisited. Nat Rev Mol Cell Biol 9:628-638.
3. Lee P, et al. (2009) Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 458:519-523.
4. Chun HJ, et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395-399.
5. Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483-1494.
6. Williams H, Flohr C (2006) How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 118:209-213.
7. Grewe M, et al. (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-361.
8. Scharschmidt TC, Segre JA (2008) Modeling atopic dermatitis with increasingly complex mouse models. J Invest Dermatol 128:1061-1064.
9. Kovalenko A, et al. (2009) Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 206:2161-2177.
10. Aberg KM, et al. (2007) Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 117:3339-3349.
11. Schmidt-Weber CB, Akdis M, Akdis CA (2007) TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120:247-254.
12. Bonecchi R, et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
13. Pivarcsi A, Homey B (2005) Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep 5:284-290.
14. Tanaka T, et al. (2001) Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int Arch Allergy Immunol 125:236-240.
15. Konishi H, et al. (2002) IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 99:11340-11345.
16. Hamid Q, et al. (1996) In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 98:225-231.
17. Damsgaard TE, Olesen AB, Sørensen FB, Thestrup-Pedersen K, Schiøtz PO (1997) Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res 289:256-260.
18. Werfel T, Kapp A (1998) Environmental and other major provocation factors in atopic dermatitis. Allergy 53:731-739.
19. Stenn KS, Balin AK, Higgins T, Stenn JO (1981) Spongiosis. J Am Acad Dermatol 5:213-214.
20. Jamora C, Fuchs E (2002) Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 4:E101-E108.
21. Palmer CN, et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446.
22. Demehri S, et al. (2008) Notch-deficient skininducesalethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol 6:e123.
23. Bogiatzi SI, et al. (2007) Cutting edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 178:3373-3377.
24. Giannelli G, et al. (2002) Gelatinase expression at positive patch test reactions. Contact Dermat 46:280-285.
25. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
26. Trautmann A, et al. (2001) The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 117:927-934.
27. Nichols KM, Cook-Bolden FE (2009) Allergic skin disease: Major highlights and recent advances. Med Clin North Am 93:1211-1224.
28. Akdis CA, et al.; European Academy of Allergology; Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 61:969-987.
29. Kobayashi H, Aiba S, Yoshino Y, Tagami H (2003) Acute cutaneous barrier disruption activates epidermal p44/42 and p38 mitogen-activated protein kinases in human and hairless guinea pig skin. Exp Dermatol 12:734-746.
30. Kähäri VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6:199-213.